Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Known anti-HIV compound also shows potential in treating immune disorders

Aug. 20, 1999

SangStat's cold storage solution for donor hearts cleared by FDA

Aug. 19, 1999

New transplant agent marketed by Roche in U.K.

Aug. 18, 1999

Isotechnika advances development of new immunosuppressant

Aug. 17, 1999

Cangene receives notification of fast-track status for new anti-chickenpox product

Aug. 16, 1999

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Aug. 16, 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Aug. 16, 1999

Aviron's EBV vaccine completes phase I trial

Aug. 13, 1999

Aquila Biopharmaceuticals receives SBIR grant for CD1 tuberculosis vaccine

Aug. 13, 1999

Viron Therapeutics awarded US patent for use of viral proteins as antiinflammatory agents

Aug. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...